About
Small Molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalSoutheastern U.S.
Clinical Trials (9)
View allTotal Trials
9
As Lead Sponsor
6
As Collaborator
3
Total Enrollment
2,579
By Phase
PHASE1: 2PHASE3: 4PHASE2: 3
By Status
COMPLETED: 8UNKNOWN: 1
Clinical Trials Pipeline9 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Today
Hover over trial bars to see details
Recent Trials
NCT04882319Lead Sponsor
Irritation and Sensitization Study of HP-5000 Topical System
PHASE1Completed
200 participants
Started: Jun 3, 2021 · Completed: Mar 11, 2022
NCT04683627Lead Sponsor
A 12-week Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Osteoarthritis Pain of the Knee
PHASE3Completed
370 participants
Started: Dec 29, 2020 · Completed: Jul 25, 2022
NCT04624867Lead Sponsor
Study Will Assess Skin Irritation and Sensitization for HP-1050 Patch
PHASE1Unknown
240 participants
Started: Nov 3, 2020 · Completed: Jan 31, 2022
NCT03277066Lead Sponsor
A 4-week Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Knee Osteoarthritis
PHASE2Completed
289 participants
Started: Sep 7, 2017 · Completed: Sep 25, 2019
NCT02876900Lead Sponsor
Study to Assess Efficacy and Safety of HP3070 in Subjects Diagnosed With Schizophrenia.
PHASE3Completed
617 participants
Started: Aug 31, 2016 · Completed: Jun 30, 2018
Locations (1)
Headquarters
Miami, FL, United States
Map
Loading map...